Figure 3.
Eact mediates its apoptotic effects via Ano1. (A) RLMVECs were transfected with either scrambled or Ano1-targeted siRNA, and Ano1 expression was assessed using immunoblot (n = 3, *P < 0.05). (B) RLMVECs were transfected with scrambled or Ano1 targeted siRNA and then treated with vehicle or 10 μM Eact for 24 hours. Expression of cleaved caspase-3 and vinculin (loading control) was then evaluated by immunoblot (n = 3, ANOVA with Tukey multiple comparison, *P < 0.05). (C) RLMVECs were transfected with scrambled or Ano1-targeted siRNA, and cells were counted after treatment with vehicle or 10 μM Eact for 24 hours (n = 3, ANOVA with Tukey multiple comparison, *P < 0.05). Data are presented as mean (±SEM).